The StatinAE gene, which is a fusion of murine angiostatin and endostatin genes, has been demonstrated to confer significant inhibition of subcutaneously implanted human glioblastoma and melanoma xenografts [27,32]. Here, COL18A1 is linked to glioblastoma.